El Salvador vs Mauritania: Share of people with HIV who receive antiretroviral therapy
El Salvador
76.0%
in 2024
Mauritania
76.0%
in 2024
El Salvador rank
61st
Mauritania rank
61st
Share of people with HIV who receive antiretroviral therapy over time
- El Salvador
- Mauritania
How they compare
El Salvador currently reports 76.0% against 76.0% in Mauritania, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mauritania ahead.
El Salvador ranks 61st and Mauritania ranks 61st of 143 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 4.1% | 8.9% | El Salvador |
| 2010s | 55.4% | 32.0% | 23.4% | El Salvador |
| 2020s | 74.4% | 64.2% | 10.2% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, El Salvador or Mauritania?
- El Salvador, at 76.0% against 76.0% in Mauritania as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between El Salvador and Mauritania?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do El Salvador and Mauritania rank globally for share of people with hiv who receive antiretroviral therapy?
- El Salvador ranks 61st and Mauritania ranks 61st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.